FSID is hiring a geospatial data scientist. Come join our fun team! fsid.co/careers/gds/

The impact of the PEPFAR funding freeze on HIV deaths and infections: a mathematical modelling study of seven countries in sub-Saharan Africa The sudden cessation of #PEPFAR funding likely results in tens of thousands of #HIV deaths and new infections www.thelancet.com/journals/ecl... #MedSky

The 3rd edition of Health Inequality has kept aspects of the older two editions that @zetkin.bsky.social originally wrote & so many found to be an accessible way into understanding the complexities of health inequalities, but there are new bits too Here's a wee thread to explain what we've done 😉

New pre-print modelling impact of US funding cuts on HIV, #TB, MCH and family planning. We estimate impact of termination of US funding to NTPs via #USAID & The Global Fund may lead to 2.2 (1.5-2.9) million excess TB deaths between 2025 and 2040, reversing over a decade of progress. bit.ly/4lowp18

It's #WorldTBDay, so if you want to learn more about working in #tuberculosis research, we have just the podcast for you! Last year on our Trial Talk podcast, we interviewed #TB #ClinicalTrials legends Andrew Nunn and Sarah Meredith about their accomplished careers. Tune in 👇

Today is #WorldTBDay. #Tuberculosis - or TB - is caused by bacteria Mycobacterium tuberculosis that mainly affects the lungs. Common symptoms include ❗️ Cough ❗️ Chest pains ❗️ Weight loss ❗️ Fever ❗️ Night sweats Learn more about TB 👉 bit.ly/3yYNwzx #EndTB

Tuberculosis once affected almost everyone, but now it “travels the paths of injustice that we blazed for it,” says author @johngreensbluesky.bsky.social. He joins us to discuss his new book.

This 😭 via @economist.com

The estimands framework encourages #ClinicalTrials researchers to precisely define their research question, reducing ambiguity when interpreting the results. This paper explores the application of the estimands framework to trials in #IBD #InflammatoryBowelDisease. 👇

New research Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis recurrence in HIV-negative adults successfully treated for pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trial www.thelancet.com/journals/lan...

Sometimes working in science is tough (public health is in a bad space at this point in time), but the joy of finding things out and generating new knowledge - makes up for it www.bbc.co.uk/iplayer/epis...

Do you work in #ClinicalTrials? Using the estimands framework can ensure your study answers the most relevant research question. In this podcast episode, @brennankahan.bsky.social discusses his work on estimands. 🎧Listen to short clip below & tune in to the episode👉 https://buff.ly/3PtETFq

⭐Tomorrow, Vanessa Didelez will present "Statistical Methods for Causal Inference with Time-to-Event Data in Epidemiology" at @bemcolloquium.bsky.social! 🗓️ Wed. Jan. 8 🕔 16:00 Berlin time (CET) 📍 Zoom webinar Abstract + webinar sign up link: bemcolloquium.com/meetings-cal... #EpiSky #CausalSky

Stayed up to watch the predicted snowfall ❄️. And was not disappointed - views of silent snowy trees and gardens outside. ☃️ London is magical when it snows. Hope the snow will still be there in the morning 🤞🏼

Love this poster! #medsky

State of the art #review on lung pathology of #tuberculosis www.science.org/doi/10.1126/...

All I want for Christmas is to know whether eating carrots lead to poor reindeer performance... (and time to post-prandial reindeer laziness) 🤶 Commentary by @suziecro.bsky.social & Rachel Phillips trialsjournal.biomedcentral.com/articles/10....

Useful thread on challenges in implementing reproducible data analysis work flows 👇

#Tuberculosis levels in #England increased by 11% in 2023 #TB www.gov.uk/government/n...

The {marginaleffects} package is an EXTREMELY useful tool for R & Python users that revolutionises the interpretation of models with complicated non-linear features. Be sure to check out this introduction from @vincentab.bsky.social, @noahgreifer.bsky.social. and @andrew.heiss.phd! #EpiSky

Highly recommended to follow this course, even if only able to do so online. I have found both the YouTube videos and textbook very useful.

As I wrote about in worksinprogress.co/issue/why-we..., putting together funding, recruiting staff, setting up operations, etc. meant a 4 year delay before starting a pilot roll-out study of malaria vaccines. This stuff really matters

Very important finding from Joowhan Sung and Emily Kendall, presented at the Asymptomatic TB session at the #TBUnion conference last week!

"Why doesn't the NHS use its GP data?". Because of privacy... Because it's hard... But we solved it. We developed new privacy protections... We built docs.OpenSAFELY.org! 181 projects! 31 organisations! Now, they come together, for the first time, in 3D! www.bennett.ox.ac.uk/blog/2024/10...

As always, #UnionConf2024 was fantastic. This year, I especially enjoyed the TBScience sessions, focus on pharmacology and discussions with catching up with colleagues. Bali was magnificent 🏖️

Fantastic day sightseeing with the LSHTM TB modelling group #Union2024. Ready for a week of TB research 🤓

It's almost time to exchange misty, chilly autumn 🍂 London for sunny Indonesia 🇮🇩 to attend the #Union2024 world conference on lung health. As usual - too many excellent sessions simultaneously and choices will need to be made be made. Look forward to catching up with colleagues 🏖️.

We've got a brand new, baby website for Positron! Take a look if you are interested in getting started, and please let us know how it goes: positron.posit.co

beautiful edinburgh… looking forward to another day of #ictmc2024 tomorrow 💃🏻🏴󠁧󠁢󠁳󠁣󠁴󠁿

Enroute to the much awaited #ictmc2024. Look forward to 3 days of the latest on trial methodology 🎉🤓

In our scoping review, analysing data from 🤯 105 studies - we assessed the impact of DATs on implementation outcomes 1⃣patient engagement with DAT; 2⃣healthcare worker use of the system; 3⃣ extent to which 🧰+ 📲+ 👩‍⚕️+💻+☎️ was used as intended; 4⃣whether DATs were integrated 🩺 www.medrxiv.org/content/10.1...

Technology 🤳 used to support 💊 adherence to tuberculosis treatment may improve treatment outcomes by ⬇️ 😷recurrence and 🦠resistance. However - in some settings - studies found limited impact on health outcomes. See our work from ASCENT-Ethiopia 🇪🇹 www.medrxiv.org/content/10.1...

Bluesky now has over 10 million users, and I was #1,534,546! #earlyadopter 👍

Excited for @ictmc2024 - not only because of the conference party @NtlMuseumsScot💃 I'll be discussing methods for estimating equity-efficiency trade-offs using data from cluster randomised trials #ASCENT-Ethiopia. 1 Oct PS.3D-5 15:10 Kilsyth-LevelO. If you are attending, please do say hi.

Pretty map by statistician Jacques Bertillon plotting out the movement of books in municipal libraries of Paris for the year 1888. Readers could borrow books for free or read them on site. The vast majority chose to take books home. And the most popular genre? Novels of course! (Source: Gallica) 🗃️

Are you at UCL & do you write data management plans, collect/ clean data, script data transformations or prepare data for sharing? If so, you're a Data Steward! Join the new Research Data Stewardship Community! forms.office.com/e/pC1qdjSqFL 🧪📊 #DataSteward #ResearchData #DataManagement #metasci

Just discovered the Causal Quartet by @lucystats.bsky.social, @travisgerke.bsky.social, and @malcolmbarrett.malco.io: four datasets that have the same unadjusted casaul relationship between treatment/outcome but different true effects. This is great for teaching DAG-based causal inference! #rstats

Beautiful day in Paris, after a very busy and fantastic #Union conference discussing tuberculosis interventions. #seeyouagainnextyear

Anyone kind enough to playtest the #rstats memory mini-game I've mocked up for a lecture icebreaker? 🙏 There are bound to be bugs somewhere. Planning on a few more #rstats #statsed themed ones for next semester, ideas welcomed! statbiscuit.github.io/mini_games/m... sc: github.com/statbiscuit/...

New paper: ‘How to check a simulation study’ Ever run a simulation study and realised the results don’t make sense or you don’t believe them? Then this one is for you because we’ve been there (too many times)! academic.oup.com/ije/advance-...

📣Our paper on the risk factors for poor engagement with a digital adherence technology used to support tuberculosis treatment adherence in Ethiopia is available. bmcpublichealth.biomedcentral.com/articles/10.... We found that the odds of poor engagement was lower among wealthier participants.